Journal of Surgical Research
Volume 140, Issue 2 , Pages 199-203 , 15 June 2007

Mast Cell-Derived Cathepsin g: A Possible Role in The Adverse Remodeling of The Failing Human Heart

  • Jama Jahanyar, M.D., Ph.D.

      Affiliations

    • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Michael E. DeBakey Department of Surgery, Division of Transplant and Assist Devices, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030.
    • ,
  • Keith A. Youker, Ph.D.

      Affiliations

    • Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas
    • ,
  • Matthias Loebe, M.D., Ph.D.

      Affiliations

    • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas
    • ,
  • Christian Assad-Kottner, M.D.

      Affiliations

    • Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas
    • ,
  • Michael M. Koerner, M.D., Ph.D.

      Affiliations

    • Department of Medicine, Baylor College of Medicine, Houston, Texas
    • ,
  • Guillermo Torre-Amione, M.D., Ph.D.

      Affiliations

    • Methodist DeBakey Heart Center, The Methodist Hospital, Houston, Texas
    • ,
  • George P. Noon, M.D.

      Affiliations

    • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas

Received 4 December 2006

References 

  1. Levin HR, Oz MC, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717
  2. Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542
  3. Reilly CF, Tewksbury DA, Schechter NM, et al. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem. 1982;257:8619
  4. Akgul A, Youker KA, Noon GP, et al. Quantitative changes in mast cell populations after left ventricular assist device implantation. ASAIO J. 2005;51:275
  5. Bruckner BA, Razeghi P, Stetson S, et al. Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant. 2004;23:36
  6. Bruckner BA, Stetson SJ, Farmer JA, et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg. 2000;180:498;Discussion 501
  7. Bruckner BA, Stetson SJ, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant. 2001;20:457
  8. Hara M, Ono K, Hwang MW, et al. Evidence for a role of mast cells in the evolution to congestive heart failure. J Exp Med. 2002;195:375
  9. Brower GL, Janicki JS. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Cardiac Fail. 2005;11:548
  10. Matsumoto T, Wada A, Tsutamoto T, et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 2003;107:2555
  11. Shiota N, Rysa J, Kovanen PT, et al. A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens. 2003;21:1935
  12. Patella V, de Crescenzo G, Lamparter-Schummert B, et al. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res. 1997;46(Suppl 1):S31
  13. Palladini G, Tozzi R, Perlini S. Cardiac mast cells in the transition to heart failure: innocent bystanders or key actors?. J Hypertens. 2003;21:1823
  14. Janicki JS, Brower GL, Gardner JD, et al. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res. 2006;69:657
  15. Hara M, Matsumori A, Ono K, et al. Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro. Circulation. 1999;100:1443
  16. Akgul A, Skrabal CA, Thompson LO, et al. Role of mast cells and their mediators in failing myocardium under mechanical ventricular support. J Heart Lung Transplant. 2004;23:709
  17. Lichtbroun AS, Sandhaus LM, Giorno RC, et al. Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am J Med. 1990;89:372
  18. Palaniyandi Selvaraj S, Watanabe K, Ma M, et al. Involvement of mast cells in the development of fibrosis in rats with postmyocarditis dilated cardiomyopathy. Biol Pharmaceut Bull. 2005;28:2128
  19. Schechter NM, Irani AM, Sprows JL, et al. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. J Immunol. 1990;145:2652
  20. Schwartz LB. Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol Biol. 2006;315:53
  21. Helske S, Syvaranta S, Kupari M, et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur Heart J. 2006;27:1495
  22. Legedz L, Randon J, Sessa C, et al. Cathepsin G is associated with atheroma formation in human carotid artery. J Hypertens. 2004;22:157
  23. Brower GL, Chancey AL, Thanigaraj S, et al. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol. 2002;283:H518
  24. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem. 1997;378:151
  25. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B. Eur J Biochem/FEBS. 1994;223:171
  26. Mizutani H, Schechter N, Lazarus G, et al. Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med. 1991;174:821

PII: S0022-4804(07)00120-5

doi: 10.1016/j.jss.2007.02.040

Journal of Surgical Research
Volume 140, Issue 2 , Pages 199-203 , 15 June 2007

Article Tools

* Image Usage & Resolution